Citation

Popovici-Muller J, Lemieux RM, Artin E, Saunders JO, Salituro FG, Travins J, Cianchetta G, Cai Z, Zhou D, Cui D, Chen P, Straley K, Tobin E, Wang F, David MD, Penard-Lacronique V, Quivoron C, Saada V, de Botton S, Gross S, Dang L, Yang H, Utley L, Chen Y, Kim H, Jin S, Gu Z, Yao G, Luo Z, Lv X, Fang C, Yan L, Olaharski A, Silverman L, Biller S, Su SM, Yen K.: Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers. ACS Med Chem Lett, Volume 9 (4), 2018

Authors

Artin E, Biller S, Cai Z, Chen P, Chen Y, Cianchetta G, Cui D, Dang L, David MD, de Botton S, Fang C, Gross S, Gu Z, Jin S, Kim H, Lemieux RM, Luo Z, Lv X, Olaharski A, Penard-Lacronique V, Popovici-Muller J, Quivoron C, Saada V, Salituro FG, Saunders JO, Silverman L, Straley K, Su SM, Tobin E, Travins J, Utley L, Wang F, Yan L, Yang H, Yao G, Yen K., Zhou D

Journal

ACS Med Chem Lett

Year

2018

DOI

10.1021/acsmedchemlett.7b00421

PubMed

29670690

Machine-readable

REST APIRDF